/Companies

Diasome

5 known investors

Find your way into Diasome

129 people in our graph can introduce you to the Diasome team.

Sign up to see every warm intro you have to Diasome

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Diasome team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Diasome develops metabolic therapies using its HDV platform to enable targeted drug delivery for treating diabetes, obesity, and metabolic diseases. The company focuses on translating therapeutic insights to restore metabolic function using endogenous mechanisms.

Founders & leadership

RGRobert Geho
Robert GehoCo-Founder, Chief Executive OfficerRobert Geho co-founded Diasome in 2004 and serves as CEO; he has over 30 years of experience in hepatic-directed drug delivery and led early clinical studies of liver-targeted insulin therapy. He holds an MBA from Case Western Reserve University and previously co-founded SDG, Inc., a life sciences holding company.
WB
W. Blair GehoCo-Founder, Chief Scientific OfficerW. Blair Geho is a pharmaceutical researcher who led development of the first approved bisphosphonate and bone imaging agent at Procter & Gamble, and invented the HDV liver targeting platform used in oral insulin and metabolic therapies.

Investors · 5

JDRF T1D Fundlisted by JDRF T1D FundBoston

How we know: funding news · press coverage · Not right? Tell us

Also in the syndicate · 3

Black Beret Life SciencesJDRFMcDonald Partners

Funding

SEC filings, press & company announcements
  • Undisclosed amountseries A roundJul 2017

    Medicxi (lead), Black Beret Life Sciences, JDRF, McDonald Partners

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Diasome do?
Diasome develops metabolic therapies using its HDV platform to enable targeted drug delivery for treating diabetes, obesity, and metabolic diseases. The company focuses on translating therapeutic insights to restore metabolic function using endogenous mechanisms.
Who founded Diasome?
Diasome was founded by Robert Geho, W. Blair Geho.
Who are Diasome's investors?
Diasome's investors include JDRF T1D Fund, Medicxi.